It is intriguing to reveal the coexistence of MLL amplication and CDKN2A deletions in AML-M5 and the cooperation of these genes rearrangements in leukemogenesis of AML-M5 needs to be further clarified. The gene discussed is CDKN2A; the disease is acute myeloid leukemia.